<DOC>
	<DOCNO>NCT00939185</DOCNO>
	<brief_summary>The objective study obtain data safety , tolerability compliance Zithromax child bacterial infection upper low respiratory tract .</brief_summary>
	<brief_title>Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections</brief_title>
	<detailed_description>Patients recruit outpatient department participate sites/hospitals/clinics .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Patients respiratory tract infection receive azithromycin accord approved SPC noninterventional study . According approve Summary Product Characteristics ( SPC ) Azithromycin non interventional study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Compliance Safety Study Children Upper Lower Respiratory Tract Infections</keyword>
</DOC>